Emergency room visits attributed to popular weight loss drugs such as Ozempic and Wegovy remain quite rare overall, but do ...

Primary care doctors can treat most patients with diabetes, but occasionally, you may want to call in a specialist. Here’s ...

A real-world study finds cardiovascular and survival benefits from dual therapy in patients with type 2 diabetes.

Continuous glucose monitoring with low-glucose alerts shows potential for reducing hypoglycemia risk in insulin-treated ...

Use of cutting-edge weight-loss drugs like Ozempic and Zepbound has increased dramatically among people with type 1 diabetes, raising safety concerns among experts, a new study says.

Zimislecel, Vertex’s investigational fully differentiated islet cell therapy with standard immunosuppression, is in the Phase 3 portion of the ...

There’s no question about the popularity of GLP-1 weight loss drugs like Ozempic and Wegovy, but some doctors are worried the ...

Despite consistent improvements in glycemic outcomes across simulations, real-world adoption is lagging. The study finds that ...

Health authorities around the world have deemed glycerol safe for consumption, including the FDA and the World Health ...

‘It feels like my body has fallen off a cliff’: The patients still living with long Covid While much of the world has moved on from the pandemic, many continue to battle health problems Save ...